OmniAb Executives Trade Small, Steady: Chief Legal Officer Buys More While CFO and CEO Flip Shares, Hinting at Liquidity Management Over Market Moves

Insider Activity at OmniAb Inc. – What the Numbers Say The latest filing from Chief Legal Officer Berkman Charles S shows a 18,750‑share purchase of common stock on February 18, 2026, a transaction that reflects a continuation of his long‑standing pattern of buying and selling shares in small, regular batches. The buy, executed at the market price of $1.71, follows a sell of 6,990 shares the previous day and a larger sell of 9,673 shares earlier the same day to cover tax withholding on newly vested RSUs. The net result is a modest increase in his holdings to 402,373 shares, underscoring a strategy of maintaining a steady, albeit small, stake rather than making large, directional bets on the company’s stock.

How This Fits Into Wider Insider Trends OmniAb’s executive leadership is active in the market: both the CFO, Kurt Gustafson, and the CEO, Matthew Foehr, each recorded five transactions on the same day, involving buys and sells of common stock, RSUs, and options. While the CFO’s net activity on the day was a net buy of 18,750 shares, the CEO’s activity involved a net sell of 30,843 shares, suggesting differing views on the company’s short‑term prospects. The pattern of frequent, relatively small trades across the top leadership cadre hints at a focus on liquidity management and tax optimization rather than a coordinated effort to influence share price.

Implications for Investors From an investor’s perspective, Berkman’s continued accumulation of shares—despite a negative earnings‑to‑price ratio of –2.66—signals confidence in OmniAb’s long‑term value proposition. The company’s core business of therapeutic antibody discovery remains a high‑growth niche, yet the current share price, sitting roughly 55 % below its 52‑week high, presents a valuation discount. The insider activity, combined with the social‑media sentiment score of +67 and a buzz level of 198 % on the day of the transaction, suggests a modest positive reception among retail investors, though institutional sentiment may remain cautious given the lack of recent earnings releases.

Berkman Charles S – A Profile Based on Historical Activity Reviewing Berkman’s trade history reveals a pattern of regular, incremental adjustments: he has repeatedly bought common stock in the range of 13,542 to 15,621 shares and sold similar quantities in the days that follow, often aligning his sales with RSU vesting dates. His RSU activity—selling 18,750 units in a single transaction to cover tax obligations—demonstrates a disciplined approach to tax planning. The cumulative effect of his trades has kept his holdings relatively stable over the past year, indicating a long‑term belief in the company’s trajectory while avoiding large, market‑moving positions.

Bottom Line For investors monitoring OmniAb, the insider buying by Chief Legal Officer Berkman, alongside the active but balanced trading of the CFO and CEO, paints a picture of executives managing liquidity and tax liabilities while maintaining confidence in the company’s underlying technology. The current price, well below its historical peak and trading at a discount to book value, may offer an entry point for those who share that confidence, but the negative earnings‑to‑price ratio and ongoing market volatility warrant cautious evaluation of the company’s near‑term outlook.